Log in to save to my catalogue

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based...

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5518863

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study

About this item

Full title

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2017-06, Vol.116 (12), p.1652-1659

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background:
Statin use after colorectal cancer diagnosis may improve survival but evidence from observational studies is conflicting. The anti-cancer effect of statins may be restricted to certain molecular subgroups. In this population-based cohort study, the interaction between p53 and 3-hydroxy-3-methylglutaryl coenzyme-A reductase (HMGCR) ex...

Alternative Titles

Full title

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5518863

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5518863

Other Identifiers

ISSN

0007-0920

E-ISSN

1532-1827

DOI

10.1038/bjc.2017.139

How to access this item